Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans
Oncotarget , Volume 6 - Issue 30 p. 29818- 29832
Despite numerous developed drugs based on glucose metabolism interventions for treatment of age-related diseases such as diabetes neuropathies (DNs), DNs are still increasing in patients with type 1 or type 2 diabetes (T1D, T2D). We aimed to identify novel candidates in adipose tissue (AT) and pancreas with T2D for targeting to develop new drugs for DNs therapy. AT-T2D displayed 15 (e.g. SYT4 up-regulated and VGF down-regulated) and pancreas-T2D showed 10 (e.g. BAG3 up-regulated, VAV3 and APOA1 down-regulated) highly differentially expressed genes with neuronal functions as compared to control tissues. ELISA was blindly performed to measure proteins of 5 most differentially expressed genes in 41 human subjects. SYT4 protein was upregulated, VAV3 and APOA1 were down-regulated, and BAG3 remained unchanged in 1- Obese and 2- Obese-T2D without insulin, VGF protein was higher in these two groups as well as in group 3- Obese-T2D receiving insulin than 4-lean subjects. Interaction networks analysis of these 5 genes showed several metabolic pathways (e.g. lipid metabolism and insulin signaling). Pancreas is a novel site for APOA1 synthesis. VGF is synthesized in AT and could be considered as good diagnostic, and even prognostic, marker for age-induced diseases obesity and T2D. This study provides new targets for rational drugs development for the therapy of age-related DNs.
|, , , ,|
|Organisation||Department of Internal Medicine|
Rahimi, M, Vinciguerra, M, Daghighi, M, Özcan, B, Akbarkhanzadeh, V, Sheedfar, F, … Rezaee, F. (2015). Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans. Oncotarget, 6(30), 29818–29832. doi:10.18632/oncotarget.4904